Thomas Pfisterer
Vermögen: 10 Mio $ am 30.06.2026
Vermögen: 10 Mio $ am 30.06.2026
Thomas Pfisterer currently works at InSphero AG, as Non-Executive Director, Lakewood-Amedex, Inc., as Director from 2022, Sermonix Pharmaceuticals LLC, as Director, Stade Français Paris SA, as Non-Executive Director, Imvax, Inc., as Non-Executive Director, and Bloom Diagnostics AG, as Director.
Mr. Pfisterer also formerly worked at ADC Therapeutics SA, as Non-Executive Director and WILD Flavors GmbH, as Head-Strategic Development from 2011 to 2015.
Mr. Pfisterer received his graduate degree from the University of Cambridge and undergraduate degree from the University of St. Gallen.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
ADC THERAPEUTICS LTD 7,7 % | 15.05.2025 | 9 788 944 ( 7,7 % ) | 10 Mio $ | 30.06.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
InSphero AG
InSphero AG BiotechnologyHealth Technology Supplies organotypic 3D microtissues for efficiency testing and toxicology in drug development | Direktor/Vorstandsmitglied | - |
Sermonix Pharmaceuticals LLC
Sermonix Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Direktor/Vorstandsmitglied | - |
Stade Français Paris SA
Stade Français Paris SA Movies/EntertainmentConsumer Services Owns and operates rugby union club | Direktor/Vorstandsmitglied | - |
ImVax, Inc.
ImVax, Inc. BiotechnologyHealth Technology Engages in research and development in biotechnology | Direktor/Vorstandsmitglied | - |
Bloom Diagnostics AG
Bloom Diagnostics AG Packaged SoftwareTechnology Services Develops diagnostics platform | Direktor/Vorstandsmitglied | - |
Lakewood-Amedex, Inc.
Lakewood-Amedex, Inc. Pharmaceuticals: MajorHealth Technology Develops anti-infective pharmaceuticals for the treatment of serious infectious diseases | Direktor/Vorstandsmitglied | 25.01.2022 |
| Unternehmen | Position | Ende |
|---|---|---|
WILD Flavors GmbH
WILD Flavors GmbH Food: Specialty/CandyConsumer Non-Durables Operates as a holding company with interests in flavoring extracts, food coloring and similar products | Corporate Officer/Principal | 02.01.2015 |
| ADC THERAPEUTICS SA | Direktor/Vorstandsmitglied | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 10 |
|---|---|
University of Cambridge
University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of St. Gallen
University of St. Gallen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
InSphero AG
InSphero AG BiotechnologyHealth Technology Supplies organotypic 3D microtissues for efficiency testing and toxicology in drug development | Health Technology |
WILD Flavors GmbH
WILD Flavors GmbH Food: Specialty/CandyConsumer Non-Durables Operates as a holding company with interests in flavoring extracts, food coloring and similar products | Consumer Non-Durables |
ADC Therapeutics SA
ADC Therapeutics SA Pharmaceuticals: MajorHealth Technology Develops proprietary antibody drug conjugates for the treatment of both solid and hematological cancers | Health Technology |
Lakewood-Amedex, Inc.
Lakewood-Amedex, Inc. Pharmaceuticals: MajorHealth Technology Develops anti-infective pharmaceuticals for the treatment of serious infectious diseases | Health Technology |
Sermonix Pharmaceuticals LLC
Sermonix Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Stade Français Paris SA
Stade Français Paris SA Movies/EntertainmentConsumer Services Owns and operates rugby union club | Consumer Services |
ImVax, Inc.
ImVax, Inc. BiotechnologyHealth Technology Engages in research and development in biotechnology | Health Technology |
Bloom Diagnostics AG
Bloom Diagnostics AG Packaged SoftwareTechnology Services Develops diagnostics platform | Technology Services |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen